Mirxes Launches Up to HK$1.1 Billion Hong Kong IPO
I'm PortAI, I can summarize articles.
Mirxes has launched its initial public offering (IPO) in Hong Kong, aiming to raise up to HK$1.09 billion by offering 46,620,000 shares at HK$23.30 each. The company plans to use the funds for R&D of its cancer screening product GASTROClear, integration of capabilities, and working capital. Allocation results will be disclosed on May 22, with trading starting on May 23. Beijing Xunrui and Evergreen Gate are cornerstone investors, while several firms are acting as joint bookrunners and lead managers for the IPO.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments